Journal article
P77 Pediatric drug data in Canadian drug monographs
Abstract
Background
Optimal drug therapy in children relies on availability of pediatric-specific information. European and American legislative initiatives have resulted in advancement of pediatric pharmacotherapy data. We aim to describe the quality and quantity of pediatric information in drug monographs of New Active Substances (NASs) approved by Health Canada.
Authors
Patel A; Duffett M; Mazer-Amirshahi M; Raja P; Chan A; van den Anker J; Samiee-Zafarghandy S
Journal
Archives of Disease in Childhood, Vol. 104, No. 6,
Publisher
BMJ
Publication Date
June 2019
DOI
10.1136/archdischild-2019-esdppp.115
ISSN
0003-9888